This is why I question FDA motives sometimes .. G
Post# of 145283
Grrr
They could approve already combo and mono , they have enough of data .,
let company have earning , and continue studies with different doses ...
Patients will benefit , company will benefit , shareholders will benefit ..
IMO only
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)